Bone metabolic markers in detecting bone metastasis of lung cancer

S. Bilgin Bayrak, E. Ceylan, M. Serter, F. Karadag, E. Demir, O. Çildag (Aydin, Turkey)

Source: Annual Congress 2010 - Biomarkers for lung cancer
Session: Biomarkers for lung cancer
Session type: Thematic Poster Session
Number: 3253

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Bilgin Bayrak, E. Ceylan, M. Serter, F. Karadag, E. Demir, O. Çildag (Aydin, Turkey). Bone metabolic markers in detecting bone metastasis of lung cancer. Eur Respir J 2010; 36: Suppl. 54, 3253

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Usefulness of bone metabolic markers in the bone metastasis from lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 269s
Year: 2002

Detection of bone metastases in patients with lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 65s
Year: 2001

Bone metastases of bronchial cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 77s
Year: 2002

The role of bisphosphonates in lung cancer patients with bone metastases
Source: Annual Congress 2007 - Therapeutic approaches in thoracic oncology
Year: 2007


Survival of lung cancer patients with bone metastases
Source: Annual Congress 2011 - Palliation and morbidity in lung cancer patients
Year: 2011

Bone marrow metastases in non-small cell lung cancer patients – a role of flow cytometry
Source: Eur Respir J 2006; 28: Suppl. 50, 782s
Year: 2006

Detection of bone metastases in patients with NSCLC
Source: Eur Respir J 2002; 20: Suppl. 38, 185s
Year: 2002

Bone and Tl-201 image overlay in detection of musculoskeletal metastases of lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 245s
Year: 2003

Comparision of FDG PET/CT and bone scanning for bone metastases in operable non-small cell lung cancer
Source: Annual Congress 2009 - Management of thoracic malignancies
Year: 2009

Prognostic significance of cytokeratin positive cells in bone marrow of non-small cell lung cancer patients
Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Year: 2008


Bone mineral density is associated with the risk of non-small cell lung cancer, the HUNT study
Source: Annual Congress 2012 - Environmental exposure and other risk factors for airway diseases
Year: 2012


Relation between bone metastasis in lung cancer and serum IL-6 levels
Source: Annual Congress 2008 - Various aspects of thoracic oncology
Year: 2008

Markers of angiogenesis in serum are correlating with disease progress in lung cancer
Source: Annual Congress 2006 - Prognostic factors in lung cancer
Year: 2006


Splenic metastasis of lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 91s
Year: 2006

Is bone marrow biopsy needed in staging small cell carcinoma?
Source: Eur Respir J 2006; 28: Suppl. 50, 83s
Year: 2006

Stem cells, their niches, and evolving concepts concerning cancer
Source: Annual Congress 2007 - Stem cells and the lung: the road from basics to clinics
Year: 2007


Monitoring of lung function and airways inflammation after bone marrow transplantation
Source: Annual Congress 2008 - Risk factors for asthma versus asthma control
Year: 2008


Increased serum levels of IL-18 are associated with lower survival and bone metastasis in non-small-cell lung cancer
Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Year: 2008

Primary giant cell tumour of bone in the lung
Source: Eur Respir J 2002; 20: Suppl. 38, 467s
Year: 2002